missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ RGPD5 Polyclonal Antibody

Beschreibung
A suggested positive control is human thymus tissue lysate. PA5-20566 can be used with blocking peptide PEP-0686.
The RANBP2-like and GRIP domain containing 5 protein (RGPD5) has high similarity to RANBP2, a large RAN-binding protein localized at the cytoplasmic side of the nuclear pore complex. The gene coding for RGPD5 is thought to have arisen from a gene duplication event of RANBP2 as these highly homologous genes are located close to each other at chromosome 2q11-q12. RGPD5 was identified as an HIV dependency factor (HDF), suggesting that RGPD5 may be an important drug target in HIV treatment. At least two isoforms of RGPD5 are known to exist, of which the shorter isoform is expressed primarily in testis, while the longer of the two is expressed at low levels in a number of somatic tissues.
Spezifikation
Spezifikation
| Antigen | RGPD5 |
| Anwendungen | Western Blot |
| Klassifikation | Polyclonal |
| Konzentration | 1 mg/mL |
| Konjugat | Unconjugated |
| Zusammensetzung | PBS with 0.02% sodium azide |
| Gen | RGPD5 |
| Gen-Zugriffsnummer | Q99666 |
| Gen-Alias | BS63; BS-63; epididymis luminal protein 161; HEL161; ran-binding protein 2-like 1; ran-binding protein 2-like 1/2; RANBP2L1; RANBP2L2; ranBP2-like 1; ranBP2-like 1/2; RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain-containing protein 5; RANBP2-like and GRIP domain-containing protein 5/6; RANBPL1; RGP5; RGP6; RGP7; RGPD5; RGPD6; RGPD7; Sperm membrane protein BS-63 |
| Gensymbole | RGPD5 |
| Mehr anzeigen |
Name des Produkts
Indem Sie auf Absenden klicken, erklären Sie sich damit einverstanden, dass Fisher Scientific sich mit Ihnen in Verbindung setzen kann, um Ihr Feedback in diesem Formular zu bearbeiten. Wir werden Ihre Informationen nicht für andere Zwecke weitergeben. Alle bereitgestellten Kontaktinformationen werden in Übereinstimmung mit unserer Datenschutzrichtlinie aufbewahrt. Datenschutzrichtlinie.
Haben Sie Verbesserungsvorschläge?